A detailed history of Jump Financial, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Jump Financial, LLC holds 12,704 shares of BPMC stock, worth $1.23 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
12,704
Holding current value
$1.23 Million
% of portfolio
0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$84.1 - $120.5 $1.07 Million - $1.53 Million
12,704 New
12,704 $1.17 Million
Q3 2023

Oct 21, 2024

BUY
$46.9 - $66.0 $204,812 - $288,222
4,367 New
4,367 $219,000
Q3 2023

Nov 07, 2023

BUY
$46.9 - $66.0 $204,812 - $288,222
4,367 New
4,367 $219,000
Q4 2022

Feb 13, 2023

BUY
$41.06 - $66.48 $1.62 Million - $2.63 Million
39,525 New
39,525 $1.73 Million
Q2 2022

Aug 09, 2022

BUY
$45.23 - $70.15 $2.06 Million - $3.2 Million
45,619 Added 357.77%
58,370 $2.95 Million
Q1 2022

May 12, 2022

BUY
$54.1 - $110.08 $689,829 - $1.4 Million
12,751 New
12,751 $814,000

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.76B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.